GL1X · GenesisL1 explorer

Research workbench

Design of organo-peptides as bipartite PCSK9 antagonists

Analyse Design of organo-peptides as bipartite PCSK9 antagonists in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6U3I
Type
protein
Length
1,028 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
Q8NBP7, A0A0U5BC76
Ligands
PQG, CA

Structure

x-ray diffraction · 4 distinct chains.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein582—Q8NBP7
B—protein10——
H—protein222——
L—protein214—A0A0U5BC76

Ligands and binding sites

  • PQG · Cis-1-amino-4-phenylcyclohexane-1-carboxylic acid · ligand · chains A, B
  • CA · Calcium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 6U3I · Design of organo-peptides as bipartite PCSK9 antagonists · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.